|
|
Article: BRIEFING - ASIA HEALTH - OCT 16, 2009.
- Article from:
- AsiaPulse News
- Article date:
- October 16, 2009
CopyrightCOPYRIGHT 2009 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
An executive briefing on Health for Oct 16, 2009, prepared by Asia Pulse (http://www.asiapulse.com), the real-time, Asia-based wire with exclusive news, commercial intelligence and business opportunities.
JAPAN'S KYOWA KIRIN TO SELL CHEMOTHERAPY PALLIATIVE TO YAKULT
TOKYO - Japanese company Kyowa Hakko Kirin Co. (TSE:4151) announced Thursday an agreement to sell to Yakult Honsha Co. (TSE:2267) the production and marketing rights to a drug that treats the side effects of chemotherapy.
With Kyowa Hakko Kogyo Co. and Kirin Pharma Co. each carrying similar treatments, last year's merger brought the combined entity's market share to roughly 60 per ...